In response to a Congressional mandate, the National Research Council conducted a review of the Small Business Innovation Research Program (SBIR) at the five federal agencies with SBIR programs with budgets in excess of $100 million (DOD, NIH, NASA, DOE, and NSF). The project was designed to answer questions of program operation and effectiveness, including the quality of the research projects being conducted under the SBIR program, the commercialization of the research, and the program's contribution to accomplishing agency missions. This report summarizes the presentations at a symposium exploring the effectiveness of Phase III of the SBIR program (the commercialization phase), during which innovations funded by Phase II awards move from the laboratory into the marketplace. No SBIR funds support Phase III; instead, to commercialize their products, small businesses are expected to garner additional funds from private investors, the capital markets, or from the agency that made the initial award.

The Small Business Innovation Research (SBIR) program is one of the largest examples of U.S. public-private partnerships. Founded in 1982, SBIR was designed to encourage small business to develop new processes and products and to provide quality research in support of the many missions of the U.S. government, including health, energy, the environment, and national defense. In response to a request from the U.S. Congress, the National Research Council assessed SBIR as administered by the five federal agencies that together make up 96 percent of program expenditures. This book, one of six in the series, reports on the SBIR program at the National Science Foundation. The study finds that the SBIR program is sound in concept and effective in practice, but that it can also be improved. Currently, the program is delivering results that meet most of the congressional objectives, including stimulating technological innovation, increasing private-sector commercialization of innovations, using small businesses to meet federal research and development needs, and fostering participation by minority and disadvantaged persons. The book suggests ways in which the program can improve operations, continue to increase private-sector commercialization, and improve participation by women and minorities.

In response to a Congressional mandate, the National Research Council conducted a review of the Small Business Innovation Research Program (SBIR) at the five federal agencies with SBIR programs with budgets in excess of $100 million (DOD, NIH, NASA, DOE, and NSF). The project was designed to answer questions of program operation and effectiveness, including the quality of the research projects being conducted under the SBIR program, the commercialization of the research, and the program's contribution to accomplishing agency missions. This report summarizes the presentations at a symposium exploring the effectiveness of Phase III of the SBIR program (the commercialization phase), during which innovations funded by Phase II awards move from the laboratory into the marketplace. No SBIR funds support Phase III; instead, to commercialize their products, small businesses are expected to garner additional funds from private investors, the capital markets, or from the agency that made the initial award.

As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a 'how-to' for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. - Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars - Case studies are interspersed throughout each chapter to support key concepts and best practices. - Enhanced by use of numerous detailed graphics, tables and flow charts

Government acts as entrepreneur when its involvement in market activities is both innovative and characterized by entrepreneurial risk. Thinking of government as entrepreneur is a unique lens through which the authors of this book examine a specific subset of U.S. government policy actions. As such, their viewpoint underscores the purposeful intent of government, its ability to act in new and innovative ways, and its willingness to undertake policy actions that have uncertain outcomes. Viewing particular policy actions through an entrepreneurial lens is useful in two broad dimensions. First, it underscores the forward looking nature of policy makers as well as the need to evaluate the social outputs and outcomes of their behavior in terms of broad spillover impacts. Second, government acting as entrepreneur parallels in concept similar activities that occur in the private sector. Government as Entrepreneur is the first broad effort to emphasize the entrepreneurial aspects of governments. It is also the first systematic treatment of U.S. innovation policies to promote the formation of strategic research partnerships. It will foster a new perspective on the role of government and how incentives for government to act entrepreneurially might be institutionalized; it will serve as a vehicle for policy makers and scholars to think about the entrepreneurial actors in an economy, in a new way.

This book provides in-depth coverage of the latest research and development activities concerning innovative wind energy technologies intended to replace fossil fuels on an economical basis. A characteristic feature of the various conversion concepts discussed is the use of tethered flying devices to substantially reduce the material consumption per installed unit and to access wind energy at higher altitudes, where the wind is more consistent. The introductory chapter describes the emergence and economic dimension of airborne wind energy. Focusing on “Fundamentals, Modeling & Simulation”, Part I includes six contributions that describe quasi-steady as well as dynamic models and simulations of airborne wind energy systems or individual components. Shifting the spotlight to “Control, Optimization & Flight State Measurement”, Part II combines one chapter on measurement techniques with five chapters on control of kite and ground stations, and two chapters on optimization. Part III on “Concept Design & Analysis” includes three chapters that present and analyze novel harvesting concepts as well as two chapters on system component design. Part IV, which centers on “Implemented Concepts”, presents five chapters on established system concepts and one chapter about a subsystem for automatic launching and landing of kites. In closing, Part V focuses with four chapters on “Technology Deployment” related to market and financing strategies, as well as on regulation and the environment. The book builds on the success of the first volume “Airborne Wind Energy” (Springer, 2013), and offers a self-contained reference guide for researchers, scientists, professionals and students. The respective chapters were contributed by a broad variety of authors: academics, practicing engineers and inventors, all of whom are experts in their respective fields.

In 1992, Congress for the first time explicitly directed the federal agencies making SBIR grants to use commercial potential as a criterion for granting SBIR awards. In response, the Department of Defense developed the SBIR Fast Track initiative, which provides expedited decision-making for SBIR awards to companies that have commitments from outside vendors. To verify the effectiveness of this initiative, the DoD asked the STEP Board to assess the operation of Fast Track. This volume of original field research includes case studies comparing Fast Track and non-Fast Track firms, a large survey of SBIR awardees, and statistical analyses of the impact of regular SBIR and Fast Track awards. Collectively, the commissioned papers and the findings and recommendations represent a significant contribution to our understanding of the SBIR program.

The Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) programs provide grant funding to help companies commercialize transformative technologies. Companies that successfully receive Phase I awards are eligible to apply for Phase II grants that can generate over a million dollars to fund product development. This book provides a straightforward, user-friendly approach to preparing a Phase II application for the National Institutes of Health (NIH) SBIR/STTR programs. A 12-week strategy is presented for developing a strong Commercialization Plan, Research Plan, and Other Components that are required for a successful application. In addition, the Review and Award process, as well as post-award considerations, are described. The Eva Garland Consulting team provides deep expertise in developing competitive SBIR/STTR proposals, having successfully assisted clients who have collectively received hundreds of millions of dollars of SBIR/STTR funding.

Medical Innovation: Concept to Commercialization is a practical, step-by-step approach on how to move a novel concept through development to realize a commercially successful product. Real-world experience cases and knowledgeable contributors provide lessons that cover the practices of diverse organizations and multiple products. This important reference will help improve success and avoid innovation failure for translational researchers, entrepreneurs, medical school educators, biomedical engineering students and faculty, and aspiring physicians.

This book provides a straightforward, user-friendly approach for preparing a NIH Phase I SBIR/STTR application. The proposal preparation process is spread over a 10-week period, and tasks are completed in a logical progression. The time requirement ranges from 10 to 25 hours per week, leaving sufficient time for other business activities. Dr. Garland draws on her years of SBIR/STTR proposal preparation experience, providing useful tips to ensure your application is highly competitive and that the entire preparation process proceeds smoothly.